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Streptococcus pyogenes (GAS) can colonise skin and mucosal membranes giving rise 26 
to carriage, localised and/or systemic infection that can range in severity (Luca-Harari 27 
et al., 2009, Fiedler et al., 2015). Traditionally S. pyogenes isolates were serotyped 28 
using M and T factor specific anti-sera that have been replaced by M genotyping 29 
(emm typing) (Johnson et al., 2006). The M protein is a major virulence factor of 30 
GAS and is a hair-like projection from the bacterial cell surface where it facilitates 31 
resistance to complement-mediated killing and aids in bacterial evasion of 32 
phagocytosis (Bessen et al., 2008). The M protein is also essential for the bacterial 33 
attachment to keratinocytes that play a significant role in infections originating at the 34 
skin surface (Biswas et al., 2001). M genotyping has made international comparisons 35 
possible and identified a world-wide perspective of strain variation. There are over 36 
200 recorded emm types and subtypes that help in the identification of outbreaks and 37 
cluster management (CDC, 2008). In Scotland, between 1999 and 2005, there was a 38 
rise in invasive GAS infections from 50 to 200 per year (HPS weekly report, 2006), a 39 
finding consistent with observations from other European countries (Luca-Harari et 40 
al., 2009, Koutouzi et al., 2015). This study reports on the distribution of GAS emm 41 
types and subtypes from invasive and non-invasive sites over a 4 year period and 42 
further identifies the most susceptible age/sex range for invasive disease.   43 
GAS isolates were referred to the reference laboratory from routine Scottish 44 
microbiology laboratories between June 2011 and April 2015. All isolates were sub-45 
cultured onto Columbia horse blood agar plates (Oxoid™) and incubated at 37˚C for 46 
24 hours in an atmosphere of 5% CO2. The isolates were phenotypically identified by 47 
colony morphology, beta haemolysis and Lancefield group identification using a 48 
Prolex™ Strep Grouping Latex Test Kit. DNA was prepared using an 49 
achromopeptidase (ACP) extraction method (Boujaafar et al., 1988). Sequencing was 50 
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performed as previously described (CDC, 2008) and sequenced on an AB 3500 xL 51 
sequencer (Molling et al., 2000).  52 
The sequences were manually edited using CLC Main Workbench software and the 53 
FASTA files were uploaded to the Blast 2.0 Server on the CDC website (CDC, 2008). 54 
The assignation of type relies upon the 90 bases encoding the N terminal 30 residues 55 
but subtypes are assigned according to the exact 180 base sequences encompassing 56 
the signal peptide (10 residues) and the 50 residues of the mature M protein.  57 
The z -test was used for statistical analysis of the data at P < 0.01. 58 
In total, eight hundred and ninety two GAS isolates were typed by emm sequencing.  59 
Table 1 shows the distribution of the major emm types from all sites but throughout 60 
the study period a total of 40 emm types were identified. The most common emm 61 
types from sterile and cutaneous sites were 1, 76 and 89 and from mucosal sites were 62 
1, 89 and 12. Over the study period, emm type 1 had the strongest association with 63 
invasive disease from sterile sites (n= 215, P < 0.001) when compared to both 64 
cutaneous and mucosal sites.  The emm types 76 and 89 were most commonly 65 
associated with cutaneous sites (p<0.001) with emm type 89 also statistically 66 
significantly linked to mucosal sites (p=0.007). The emm types 12, 75, 28 and 6 were 67 
more commonly linked to mucosal sites (p<0.001, p= 0.007, p<0.001, p=0.001). In 68 
Table 1 the emm subtype 1.52 is included to show the statistical differences within an 69 
emm type as this subtype of 1 was more commonly associated with mucosal sites 70 
(p<0.001) whereas emm type 1 was more commonly associated with sterile sites 71 
(p<0.001). Four emm types (3, 4, 5 and 22) showed no statistical preference between 72 
acquisition sites. When the non-invasive sites alone were compared, emm type 76 was 73 
statistically linked to cutaneous sites (p<0.001). In mucosal sites, the only emm type 74 
that was statistically more prevalent was 12 (p=0.007). When age and sex distribution 75 
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were analysed (Table 2), there were statistically significant differences in sex and age 76 
related disease site acquisition. The major difference between the sexes related to the 77 
age when invasive disease became most prevalent.  In the male population age groups 78 
(51-64 years and >65 years) there was a statistically significant increase in cases 79 
associated with invasive disease (p<0.001) compared to females when invasive 80 
disease was statistically (p<0.001) most prevalent in >65 year age range. Other 81 
interesting observations include the prevalence of cutaneous isolates in the female 0-4 82 
and 5-19 year age range changing to mucosal site acquisition in the 5-19 and 20-34 83 
year age range. In the male population, mucosal acquisition was most prevalent in the 84 
0-4 and 5-19 year age range with cutaneous acquisition more common in the 20-34 85 
age range.  86 
In conclusion the most prevalent emm types identified were 1, 76 and 89. This is 87 
partly mirrored in other European countries, apart from emm type 76 that was linked 88 
to a single outbreak involving PWID. In 2008, there was a Europe wide publication 89 
on emm type distribution in invasive disease covering the years 2003-4 and a wide 90 
diversity of emm types (n = 104) were found among clinical isolates of Streptococcus 91 
pyogenes from 11 European countries (Lamagni et al., 2008). The 10 most 92 
predominant emm types were emm type 1, 28, 3, 89, 87, 12, 4, 83, 81 and 5 in 93 
descending order. At the national reference laboratory (England and Wales) emm 94 
strain typing on 1,271 invasive GAS isolates was undertaken from October to June 95 
2015 (PHE, 2015). The results indicate that emm type 1 was the most common 96 
followed by 3, 12 and 89. The isolates identified in this Scottish cohort included both 97 
invasive and non invasive strains were in descending order emm type 1, 76, 89, 12, 98 
75, 28, 4 and 3.  Euro-prevalent emm type 83 was identified only once in Scottish 99 
isolates. We report that emm type 1 was most significantly associated with invasive 100 
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disease. A paediatric study (d’Humieres et al., 2015) showed that emm type 1 is also 101 
associated with the most life-threatening clinical disease manifestations. In the adult 102 
population of Europe and the USA, emm type 1 and 3 are strongly associated with 103 
invasive infections. This contrasts to Africa and Asia where emm types differ quite 104 
significantly (Steer et al., 2009, Efstratiou and Lamagni, 2016). The reasons for the 105 
different molecular epidemiology in these regions is not clear however it may relate to 106 
the high numbers of impetigo cases identified in Africa and Asia that are not mirrored 107 
in Europe and North America. Therefore it is important to be aware of increases in 108 
circulating emm types in the GAS population as between 1999 and 2005 there was a 109 
rise in iGAS infections in Scotland (HPS Weekly report, 2006) a finding consistent 110 
with observations from other European countries (Zakikhany et al., 2011, Koutozi et 111 
al., 2015, Efstratiou and Lamagni, 2016). In 2014, Scotland saw higher than expected 112 
levels of GAS and iGAS (HPS weekly report, 2015) that occurred against a backdrop 113 
of increased scarlet fever notifications in the rest of the UK. The increased iGAS 114 
cases in Scotland may be attributable to a natural cycle in disease incidence although 115 
the potential for changes in the virulence of circulating strains or increased incidence 116 
in a particular risk and age group can not be excluded and continued vigilance 117 
remains essential to spot changing disease patterns.  118 
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Table 1.  Prevalence of the top eleven Streptococcus pyogenes emm types from mucosal and cutaneous non invasive disease sites compared to 195 
invasive sterile sites and between non-invasive mucosal and cutaneous sites 196 
   197 
emm 
type/subtype*  
Cutaneous 
N (%) 
 
 
P 
Sterile site 
N (%) 
 
 
P 
Mucosal 
N (%) 
Cutaneous 
N  
 
 
P 
Mucosal 
N  
1 81 (32) <0.001 215 (66) <0.001 47 (25.2) 81  0.184 47  
76 56 (22) <0.001 24 (7.4) 0.263 9 (4.8) 56  <0.001 9  
89 41 (16) <0.001 22 (6.7) 0.007 26 (13.9) 41  0.610 26  
12 12 (4.7) 0.095 7 (2) <0.001 21 (11.3) 12  0.007 21  
75 12 (4.7) 0.095 7 (2) 0.007 13 (7) 12  0.280 13  
28 13 (5.1) 0.032 6 (1.8) <0.001 15 (8) 13  0.184 15  
4 5 (2) 0.944 6 (1.8) 0.101 8 (4.3) 5  0.138 8  
3 12 (4.7) 0.509 19 (5.8) 0.460 8 (4.3) 12  0.881 8  
5 7 (2.8) 0.631 11 (3.4) 0.818 7 (3.7) 7 0.518 7 
22 7 (2.8) 0.101 3 (0.9) 0.011 8 (4.3) 7 0.347 8 
6 7 (2.8) 0.042 2 (0.6) 0.001 9 (4.8) 7 0.226 9 
1.52* 8 (3.2) 0.119 4 (1.2) <0.001 15 (8) 8  0.018 15  
 10 
 198 
Eighteen emm types had insufficient isolates (<10) for statistical calculation. These included emm types 2, 9, 11, 18, 44, 58, 73, 77, 78, 81, 82, 199 
87, 90, 102, 103, 108, 124 and 182 that are not reported in the table. The remaining emm types were identified only once during the study time 200 
frame and were classed as rare emm types. These include 8, 29, 33, 63, 68, 80, 83, 93, 94, 101 and 179.   201 
 202 
 203 
 204 
 205 
 206 
 207 
 208 
 209 
 210 
 211 
 212 
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Table 2. The Distribution of GAS from cutaneous, mucosal and sterile site dependent on age and sex 213 
  214 
 215 
 216 
 217 
 218 
 219 
 220 
 221 
 222 
 223 
 
  Female     Male   
Age group Cutaneous (%) P Sterile (%) P Mucosal(%) Cutaneous (%) P Sterile (%)  P Mucosal (%) 
0-4 27 (19) 0.004 11 (7) 0.327 14 (11) 26 (15) 0.017 15 (7) <0.001 24 (29) 
5-19 22 (15) 0.005 8 (5) <0.001 46 (35) 21 (12) 0.019 11 (5) <0.001 22 (27) 
20-34 22 (15) 0.174 15 (10) 0.005 29 (22) 49 (28) <0.001 27 (13) 0.829 10 (12) 
35-50 34 (23)  0.373 29 (19) 0.920 26 (20) 48 (28) 0.036 38 (19) 0.772 14 (17) 
51-64 16 (11) 0.453 21 (14) 0.09 10 (8) 18 (10) 0.046 36 (18) <0.001 1 (1) 
>65 25 (17) <0.001 68 (45) <0.001 8 (6) 12 (7) <0.001 78 (38) <0.001 11 (13) 
Total 146  152  133 174  205  82 
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